Chemical Compound

4-Thiazoleacetamide, 2-amino-a-(methoxyimino)-N-(1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-, [5aR-[5aa,6ss(Z)]]- (9CI); 3H,7H-Azeto[2,1-b]furo[3,4-d][1,3]thiazine, 4-thiazoleacetamide deriv.; Ceftriaxone Sodium Imp. B, Cefotaxime Sodium Imp. E (EP); (5aR,6R)-6-[[(2Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione; Deacetylcefotaxime lactone

CAS Registry Number 66340-33-8
返回搜索 申请报价
4-Thiazoleacetamide, 2-amino-a-(methoxyimino)-N-(1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-, [5aR-[5aa,6ss(Z)]]- (9CI); 3H,7H-Azeto[2,1-b]furo[3,4-d][1,3]thiazine, 4-thiazoleacetamide deriv.; Ceftriaxone Sodium Imp. B, Cefotaxime Sodium Imp. E (EP); (5aR,6R)-6-[[(2Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione; Deacetylcefotaxime lactone 结构式
Primary record

4-Thiazoleacetamide, 2-amino-a-(methoxyimino)-N-(1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-, [5aR-[5aa,6ss(Z)]]- (9CI); 3H,7H-Azeto[2,1-b]furo[3,4-d][1,3]thiazine, 4-thiazoleacetamide deriv.; Ceftriaxone Sodium Imp. B, Cefotaxime Sodium Imp. E (EP); (5aR,6R)-6-[[(2Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione; Deacetylcefotaxime lactone

库存
8,151 克
纯度
99.5 %
CAS
66340-33-8

化合物标识与属性

CAS
66340-33-8
PubChem CID
13080558
SMILES
CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C4=C(COC4=O)CS3
Canonical SMILES
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C3=C(COC3=O)CS[C@H]12)c1csc(N)n1

名称与同义词

  • Deacetylcefotaxime lactone
  • 3-Desacetyl Cefotaxime Lactone
  • Ceftriaxone impurity B
  • Cefotaxime impurity E
  • 66340-33-8
  • Cefotaxime impurity E [EP]
  • UNII-3Z40JM5X8L
  • Ceftriaxone EP Impurity B
  • RefChem:131078
  • 3Z40JM5X8L
  • Desacetylcefotaxime Lactone
  • Cefotaxime Related Compound E
  • Cefotaxime sodium impurity E
  • Cefotaxime sodium impurity E [EP]
  • Ceftriaxone sodium impurity B
  • Ceftriaxone sodium impurity B [EP]
  • DTXSID70216550
  • Cefotaxime specified impurity E
  • Cefotaxime specified impurity E [EP]
  • orb1989615
  • SCHEMBL20965355
  • DTXCID00139041
  • AKOS030530217
  • CEFTRIAXONE SODIUM IMPURITY B [IP]
  • CEFOTAXIME IMPURITY E [EP IMPURITY]
  • PD199440
  • CEFOTAXIME RELATED COMPOUND E [USP-RS]
  • CEFTRIAXONE SODIUM IMPURITY B (IP)
  • CEFOTAXIME IMPURITY E (EP IMPURITY)
  • HY-135394
  • CS-0112380
  • FT-0665873
  • CEFOTAXIME SODIUM IMPURITY E [EP IMPURITY]
  • CEFTRIAXONE SODIUM IMPURITY B [EP IMPURITY]
  • CEFOTAXIME RELATED COMPOUND E (USP-RS)
  • CEFTRIAXONE SODIUM IMPURITY A [USP IMPURITY]
  • G14236
  • A938902
  • CEFOTAXIME SODIUM IMPURITY E (EP IMPURITY)
  • F554682
  • CEFTRIAXONE SODIUM IMPURITY A (USP IMPURITY)
  • CEFTRIAXONE SODIUM IMPURITY B (EP IMPURITY)
  • Cefotaxime EP Impurity E; Ceftriaxone EP Impurity B
  • CEFTRIAXONE SODIUM IMPURITY B (REFERENCE GRADE)
  • Q27258237
  • (2Z)-2-(2-amino-1,3-thiazol-4-yl)-N-[(4R,5R)-3,11-dioxo-10-oxa-6-thia-2-azatricyclo[6.3.0.02,5]undec-1(8)-en-4-yl]-2-methoxyiminoacetamide
  • B2694-468462
  • (5aR,6R)-6-(((2Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetyl)amino)-5a,6-dihydro-3H,7H-azeto(2,1-b)furo(3,4-d)(1,3)thiazine-1,7(4H)-dione
  • 4-Thiazoleacetamide, 2-amino-alpha-(methoxyimino)-N-(1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto(2,1-b)furo(3,4-d)(1,3)thiazin-6-yl)-, (5ar-(5aalpha,6beta(Z)))-
  • (Z)-2-(2-aminothiazol-4-yl)-N-((5aR,6R)-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-2-(methoxyimino)acetamide
  • 3H,7H-Azeto[2,1-b]furo[3,4-d][1,3]thiazine, 4-thiazoleacetamide deriv.
  • Ceftriaxone Sodium EP Impurity B(Cefotaxime EP Impurity E)Cefodizime Impurity D
  • (2Z)-2-(2-Amino-1,3-thiazol-4-yl)-N-[(5aR,6R)-1,7-dioxo-1,4,6,7-tetrahydro-3H,5aH-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-(methoxyimino)acetamide
  • (alphaZ)-2-Amino-alpha-(methoxyimino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-4-thiazoleacetamide
  • [5aR-[5a|A,6|A(Z)]]-2-Amino-|A-(methoxyimino)-N-(1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-4-thiazoleacetamide
  • [5aR-[5aalpha,6beta(Z)]]-2-Amino-alpha-(methoxyimino)-N-(1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-4-thiazoleacetamide
  • 4-THIAZOLEACETAMIDE, 2-AMINO-.ALPHA.-(METHOXYIMINO)-N-(1,4,5A,6-TETRAHYDRO-1,7-DIOXO-3H,7H-AZETO(2,1-B)FURO(3,4-D)(1,3)THIAZIN-6-YL)-, (5AR-(5A.ALPHA.,6.BETA.(Z)))-
  • 4-Thiazoleacetamide, 2-amino-a-(methoxyimino)-N-(1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-, [5aR-[5aa,6ss(Z)]]- (9CI); 3H,7H-Azeto[2,1-b]furo[3,4-d][1,3]thiazine, 4-thiazoleacetamide deriv.; Ceftriaxone Sodium Imp. B, Cefotaxime Sodium Imp. E (EP); (5aR,6R)-6-[[(2Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione; Deacetylcefotaxime lactone
  • 4-Thiazoleacetamide, 2-amino-alpha-(methoxyimino)-N-(1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-, [5aR-[5aalpha,6beta(Z)]]-
  • 4-Thiazoleacetamide, 2-amino-alpha-(methoxyimino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-, (alphaZ)-
  • 5aR,6R)-6-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione